|
CN1876187A
|
|
Double-head radical lipid prodrug
|
|
CN101055266A
|
|
Method and reagent kit for protein N-terminal peptide specific identification and sequencing
|
|
CN101055267A
|
|
Method and reagent kit for quickly identifying protein and its N-terminal sequence
|
|
CN101040851A
|
|
The use of dicaffeoylguinic acid ramification and the analog in the treatment of diabetes and the corresponding disease
|
|
CN1800387A
|
|
Small interfering RNA for suppressing multiple effect growth factor expression and its uses
|
|
CN1800373A
|
|
Hybridoma cell strain and its produced human VEGFR-3 resistant monoclonal antibody
|
|
CN1766124A
|
|
Method for detecting chronic hepatitis B sensitive gene and sensitive gene ESR1
|
|
CN1865289A
|
|
Preparation and uses of polysaccharide from urtica fissa
|
|
CN1800382A
|
|
Recombinant human hepassocin preparation method and its uses in preparing medicine for anti-liver injury
|
|
CN1800388A
|
|
Eight human miRNAs
|
|
CN1602952A
|
|
Tumor cell apoptosis accelerating medicine
|
|
CN1565434A
|
|
Orally administered Modafinil medicine compostion
|
|
CN1566128A
|
|
Sugar charcoal glycoside isoflavone compound containing alkane amine group and alkoxy substitution, process and uses thereof
|
|
CN1566144A
|
|
Functional protein in SARS coronavirus
|
|
CN1466943A
|
|
Use of trans-3,4,5-trihydroxy-diphenyl and derivant for resisting hepatitis B virus
|
|
CN1417572A
|
|
Electronic paramagnetic resonance measurement scheme of personal radiation dose
|
